Study conducted by 13 organisations found that in govt hospitals, direct median total cost for treating bloodstream infections triggered by antimicrobial-resistant bacteria was Rs 89,377.
Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.
Study by scientists associated with ICMR, Cambridge University and Christian Medical College (CMC), Vellore, was published Tuesday in the Journal of Epidemiology and Global Health.
Findings published Tuesday also said that over 39 crore deaths caused directly or indirectly by antibiotic-resistant infections are estimated to occur worldwide by 2050.
In their findings published in peer-reviewed journal PNAS, Australian scientists say antidepressants trigger defence mechanisms in bacteria causing them to resist antibiotics.
The spread of SARS-CoV-2 shows just how fast infectious agents can move with human travel. The impact of increasing antibiotic resistance is no different.
Regulator seeks feedback on allowing firms to repurchase shares via exchanges after tax changes, as markets reel from war-led selloff and foreign outflows.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS